Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 1/20 | 0.58 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6666657 | 1.00 | FABP7 (0.58) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL10917021 | 1.00 | FABP7 (0.58) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27765522 | 0.98 | FABP7 (0.57) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL27944947 | 0.98 | FABP7 (0.57) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL702762 | 0.95 | ALDH1A1 (0.66) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL595366 | 0.95 | ALDH1A1 (0.66) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL9982540 | 0.95 | ALDH1A1 (0.66) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL15152701 | 0.93 | FABP7 (0.53) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL15798022 | 0.93 | FABP7 (0.56) | FABP7FABP5ALDH1A1GAASMN1; SMN2 | |
| SCHEMBL16203189 | 0.93 | FABP7 (0.53) | FABP7FABP5ALDH1A1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103923765-A | Detergent Composition For Process Of Manufacturing Semiconductors And Displays | COWON INNOTECH INC | 2014-07-16 | — | — | CN | claimed |
| CN-117813308-A | Nitrogen-containing condensed ring compound, preparation method and medical application thereof | 中国医药研究开发中心有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117377669-A | TYK2 inhibitor and application thereof | 苏多生物科学有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-116981672-A | Macrocyclic compounds as CFTR modulators | 爱杜西亚药品有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-109369635-B | Compound or pharmaceutically acceptable salt thereof, application thereof and pharmaceutical composition | 赛克里翁治疗有限公司 | 2023-06-30 | — | — | CN | disclosed |
| US-20230203071-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| CN-109384778-B | Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder | 赛克里翁治疗有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-110016020-B | Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof | 赛克里翁治疗有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-108912111-B | Compounds and pharmaceutical compositions | 赛克里翁治疗有限公司 | 2021-09-14 | — | — | CN | disclosed |
| CN-112996789-A | Antiviral pyridopyrazinedione compounds | 诺华股份有限公司 | 2021-06-18 | — | — | CN | disclosed |
| JP-2005082501-A | METHOD FOR MANUFACTURING PURIFIED BENZYL ESTER COMPOUND | SUMITOMO CHEMICAL CO LTD | 2005-03-31 | — | — | JP | disclosed |
| EP-1517881-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | Syngenta Participations AG (CH) | 2005-03-30 | — | — | EP | disclosed |
| CN-1186310-C | Process for preparing 3,3-dimethyl-2-formoyl cyclopropane carboxylic ester | SUMITOMO CHEMICAL CO (JP) | 2005-01-26 | — | — | CN | disclosed |
| WO-2004002943-A1 | 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-01-08 | — | — | WO | disclosed |
| CN-1312244-A | Process for preparing 3,3-dimethyl-2-formoyl cyclopropane carboxylic ester | SUMITOMO CHEMICAL CO (JP) | 2001-09-12 | — | — | CN | disclosed |
| US-5371268-A | Ortho-substituted benzyl esters of cyclopropanecarboxylic acids | BASF AKTIENGESELLSCHAFT (DE) | 1994-12-06 | — | — | US | disclosed |
| US-5066673-A | SUBSTITUTED BENZYL 2-PHENYL-1-ALK(EN)YLCYCLOPROPANE-CARBOXYLATES AND THE USE THEREOF FOR CONTROLLING PESTS | BASF AKTIENGESELLSCHAFT (DE) | 1991-11-19 | — | — | US | disclosed |
| US-4256907-A | Preparation of substituted vinylcyclopropane-carboxylic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | disclosed |
| EP-0010154-A1 | Soil insecticides containing substituted benzylcyclopropane carboxylates (I) as active compounds, preparation of these insecticides, control of soil insects by the esters (I) and substituted benzylcyclopropane carboxylates | BAYER AG (DE) | 1980-04-30 | — | — | EP | disclosed |
| US-4098817-A | OXIDATION OF CYCLOALIPHATIC COMPOUNDS | PETRO-TEX CHEMICAL CORPORATION (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203071-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | HAVCR2, MAVS, CD4 | FABP7 2967/4885FABP5 2315/4885ALDH1A1 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.